The anti-CD20 antibody rituximab reduces the Th17 cell response-Reference-Cited by-同舟云学术

The anti-CD20 antibody rituximab reduces the Th17 cell response

Published:2011-05-31 Issue:6 Volume:63 Page:1507-1516
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

van de Veerdonk Frank L.,Lauwerys Bernard,Marijnissen Renoud J.,Timmermans Kim,Di Padova Franco,Koenders Marije I.,Gutierrez-Roelens Ilse,Durez Patrick,Netea Mihai G.,van der Meer Jos W. M.,van den Berg Wim B.,Joosten Leo A. B.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.30314/fullpdf

Reference33 articles.

1. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis;Edwards;N Engl J Med,2004

2. B cells, be gone: B-cell depletion in the treatment of rheumatoid arthritis;Tsokos;N Engl J Med,2004

3. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis;Hauser;N Engl J Med,2008

4. The B cell: old player, new position on the team;McFarland;N Engl J Med,2008

5. The biological functions of T helper 17 cell effector cytokines in inflammation;Ouyang;Immunity,2008

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psoriasis and Lupus Erythematosus—Similarities and Differences between Two Autoimmune Diseases;Journal of Clinical Medicine;2024-07-25

2. Myelin-reactive B cells exacerbate CD4+ T cell-driven CNS autoimmunity in an IL-23-dependent manner;Nature Communications;2024-06-26

3. Unveiling Novel Drug Targets and Emerging Therapies for Rheumatoid Arthritis: A Comprehensive Review;ACS Pharmacology & Translational Science;2024-05-28

4. Oxidative phosphorylation regulates B cell effector cytokines and promotes inflammation in multiple sclerosis;Science Immunology;2024-05-03

5. Comparison of the Clinical Efficacy of Rituximab Infusion and Dexamethasone-Cyclophosphamide Pulse Therapy and Their Effect on Serum Th1, Th2, and Th17 Cytokines in Pemphigus Vulgaris–A Prospective, Nonrandomized, Comparative Pilot Study;Indian Dermatology Online Journal;2024-04-29